Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03VAO
|
||||
Former ID |
DNC014276
|
||||
Drug Name |
N-(3-bromophenyl)-6-fluoroquinazolin-4-amine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530473] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H9BrFN3
|
||||
Canonical SMILES |
C1=CC(=CC(=C1)Br)NC2=NC=NC3=C2C=C(C=C3)F
|
||||
InChI |
1S/C14H9BrFN3/c15-9-2-1-3-11(6-9)19-14-12-7-10(16)4-5-13(12)17-8-18-14/h1-8H,(H,17,18,19)
|
||||
InChIKey |
FQRFQQLJZXACCG-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Metabotropicglutamate receptor 1 | Target Info | Inhibitor | [530473] | |
Metabotropic glutamate receptor 5 | Target Info | Inhibitor | [530473] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | ||||
Metabotropic glutamate receptor group III pathway | |||||
Metabotropic glutamate receptor group I pathway | |||||
Endogenous cannabinoid signalingP00027:Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Endogenous cannabinoid signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.